US Stock MarketDetailed Quotes
MRK Merck & Co
- 103.120
- +1.500+1.48%
Close Nov 27 16:00 ET
- 102.810
- -0.310-0.30%
Post 20:01 ET
260.86BMarket Cap21.57P/E (TTM)
103.450High101.640Low9.80MVolume101.650Open101.620Pre Close1.01BTurnover0.39%Turnover Ratio736.57P/E (Static)2.53BShares133.73552wk High5.86P/B260.53BFloat Cap94.48052wk Low3.08Dividend TTM2.53BShs Float133.735Historical High2.99%Div YieldTTM1.78%Amplitude18.000Historical Low102.927Avg Price1Lot Size
Merck & Co Stock Forum
Sign in to post a comment
$Merck & Co (MRK.US)$ Is it a good buy ?
3
$Merck & Co (MRK.US)$ PFE LLY and this POS all set up to pop 1-2 months earlier than expected
$Merck & Co (MRK.US)$ $Incyte (INCY.US)$ is a great company. Buying it would be a good decision, unless Merck massively overpays.
3
$Merck & Co (MRK.US)$ how do drugs go up and down like this? theyre drugs, they pretty much sell themselves.
1
$Merck & Co (MRK.US)$ looks like he's going back to 2022
Before & after US election, I had sold out most of my stocks to reduce the risk and trim my portfolio.
Most of my stocks were closed out with profits but offset by losses in some underperforming stocks like $Centene (CNC.US)$ , $Nike (NKE.US)$ , $Merck & Co (MRK.US)$ and $Celsius Holdings (CELH.US)$ .
Both $NVIDIA (NVDA.US)$ and $Tesla (TSLA.US)$ are crucial in my portfolio for long term trading.
I had added more positions in Tesla after US election because I believe Te...
Most of my stocks were closed out with profits but offset by losses in some underperforming stocks like $Centene (CNC.US)$ , $Nike (NKE.US)$ , $Merck & Co (MRK.US)$ and $Celsius Holdings (CELH.US)$ .
Both $NVIDIA (NVDA.US)$ and $Tesla (TSLA.US)$ are crucial in my portfolio for long term trading.
I had added more positions in Tesla after US election because I believe Te...
+1
loading...
24
4
$Merck & Co (MRK.US)$ luckily i didn"t buy in on Wednesday hoo... feel relieve
This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
+18
15
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
101721316 : is a great investment but i won"t buy it now i will wait
itsmerky OP 101721316 : Thanks
101721316 itsmerky OP :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
you "re welcome